down arrow

Lincoln Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
552.90
14.65 (2.72%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.98 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

525.05552.95

52 Week

498.00975.00
Valuation
Technical
Day's Volume

CASH

13.98 k (-75.89%) Volume

Shareholding (Dec 2024)

FII

5.16%

Held by 44 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

49.78%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 9.06% and Operating profit at 5.80% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,107 Cr (Small Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

15.12%

stock-summary
Price to Book

1.69

Revenue and Profits (1 Year):
Net Sales:
147 Cr
(Quarterly Results - Dec 2024)
Net Profit:
21 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-19.68%
0%
-19.68%
1 Year
-8.1%
0%
-8.1%
2 Years
41.26%
0.39%
41.65%
3 Years
57.66%
1.04%
58.7%
4 Years
130.38%
1.41%
131.79%
5 Years
304.91%
2.86%
307.77%

Latest dividend: 1.5 per share ex-dividend date: Sep-15-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.06%
EBIT Growth (5y)
5.80%
EBIT to Interest (avg)
53.83
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.05
Tax Ratio
22.39%
Dividend Payout Ratio
4.12%
Pledged Shares
0
Institutional Holding
5.16%
ROCE (avg)
23.54%
ROE (avg)
15.30%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
33
Price to Book Value
1.69
EV to EBIT
10.92
EV to EBITDA
9.47
EV to Capital Employed
1.99
EV to Sales
1.48
PEG Ratio
4.99
Dividend Yield
NA
ROCE (Latest)
19.67%
ROE (Latest)
15.12%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 44 FIIs (5.16%)

Promoter with highest holding

Munjal Mahendrabhai Patel (13.37%)

Highest Public shareholder

Kishor M. Shah (2.39%)

Individual Investors Holdings

36.71%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "146.55",
          "val2": "146.45",
          "chgp": "0.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.66",
          "val2": "29.66",
          "chgp": "-20.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.73",
          "val2": "0.15",
          "chgp": "386.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.77",
          "val2": "28.04",
          "chgp": "-25.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.14%",
          "val2": "20.25%",
          "chgp": "-4.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 5.79% vs 10.42% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 7.14% vs 20.53% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "308.50",
          "val2": "291.61",
          "chgp": "5.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51.12",
          "val2": "51.87",
          "chgp": "-1.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.79",
          "val2": "0.81",
          "chgp": "-2.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50.00",
          "val2": "46.67",
          "chgp": "7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.57%",
          "val2": "17.79%",
          "chgp": "-1.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 3.88% vs 10.11% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -5.27% vs 23.84% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "455.05",
          "val2": "438.06",
          "chgp": "3.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.78",
          "val2": "81.53",
          "chgp": "-8.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.52",
          "val2": "0.96",
          "chgp": "58.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "70.77",
          "val2": "74.71",
          "chgp": "-5.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.43%",
          "val2": "18.61%",
          "chgp": "-2.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 27.98% vs 5.10% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "580.55",
          "val2": "510.31",
          "chgp": "13.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "99.91",
          "val2": "89.21",
          "chgp": "11.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.46",
          "val2": "2.03",
          "chgp": "-28.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "93.30",
          "val2": "72.90",
          "chgp": "27.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.21%",
          "val2": "17.48%",
          "chgp": "-0.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
146.55
146.45
0.07%
Operating Profit (PBDIT) excl Other Income
23.66
29.66
-20.23%
Interest
0.73
0.15
386.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
20.77
28.04
-25.93%
Operating Profit Margin (Excl OI)
16.14%
20.25%
-4.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 0.07% vs 9.48% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -25.93% vs 29.75% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
308.50
291.61
5.79%
Operating Profit (PBDIT) excl Other Income
51.12
51.87
-1.45%
Interest
0.79
0.81
-2.47%
Exceptional Items
0.00
0.00
Consolidate Net Profit
50.00
46.67
7.14%
Operating Profit Margin (Excl OI)
16.57%
17.79%
-1.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 5.79% vs 10.42% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 7.14% vs 20.53% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
455.05
438.06
3.88%
Operating Profit (PBDIT) excl Other Income
74.78
81.53
-8.28%
Interest
1.52
0.96
58.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
70.77
74.71
-5.27%
Operating Profit Margin (Excl OI)
16.43%
18.61%
-2.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 3.88% vs 10.11% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -5.27% vs 23.84% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
580.55
510.31
13.76%
Operating Profit (PBDIT) excl Other Income
99.91
89.21
11.99%
Interest
1.46
2.03
-28.08%
Exceptional Items
0.00
0.00
Consolidate Net Profit
93.30
72.90
27.98%
Operating Profit Margin (Excl OI)
17.21%
17.48%
-0.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 27.98% vs 5.10% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Lincoln Pharmaceuticals Ltd stock-summary
stock-summary
Lincoln Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
Company Coordinates stock-summary
Company Details
Lincoln House B/H Satyam Compe, Science City Road Sola Ahmedabad Gujarat : 380060
stock-summary
Tel: 91-079-67778000
stock-summary
http://www.lincolnpharma.com
stock-summary
info@lincolnpharma.com
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."